The global market for over-the- counter (OTC) drugs, vitamins and dietary supplements is expected to grow from $276.9 billion in 2025 and is projected to reach $371.7 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.1% during the forecast period of 2025 to 2030.
Over-the-counter (OTC) medicines are nonprescription medications that individuals can purchase directly without a doctor’s prescription. OTC drugs effectively treat various disorders and their associated symptoms, including pain, coughs, colds, diarrhea, constipation and acne. Vitamins and dietary supplements are intended to provide essential nutrients to fill potential gaps in a person’s diet for maintaining an active and healthy lifestyle. Common dietary supplements include vitamins, minerals, herbs and botanicals, probiotics, fish oil and more. To capture product-specific nuances, this report, where relevant, treats the OTC drugs market as being distinct from the vitamins and drug supplement market in its analysis.
Key players in the global OTC drugs, vitamins and dietary supplements market include Haleon Group of Companies, Kenvue, Opella Healthcare Group SAS, Bayer, Procter & Gamble, Reckitt, STADA Arzneimittel AG, Amway, Nestlé, Pharmavite, H&H Group, Herbalife, Church & Dwight and GNC Holdings. The market is highly fragmented. In addition to industry leaders, domestic players and store brands also play a vital role. Companies compete in terms of pricing strategies, product quality, innovation, brand recognition and distribution channels.
The report focuses on the major driving trends and challenges that affect the OTC drugs, vitamins and dietary supplements market and its vendor landscape. It covers the latest new products, acquisitions and collaborations taking place in this market. It also analyzes environmental, social, and corporate governance (ESG) developments and discusses emerging opportunities and challenges related to the market.
The report concludes with an analysis of the competitive landscape of this market, providing the ranking and share of key players. It also has a company profiles section that is dedicated to providing details about leading market players.
It is important to note that this report’s scope covers only pharmacological OTC drugs and excludes any other types of drugs, such as alternative therapies. Also, dietary supplements for weight management, meal replacements, medical nutrition, sports nutrition, and skin care are not included in this report.
Over-the-counter (OTC) medicines are nonprescription medications that individuals can purchase directly without a doctor’s prescription. OTC drugs effectively treat various disorders and their associated symptoms, including pain, coughs, colds, diarrhea, constipation and acne. Vitamins and dietary supplements are intended to provide essential nutrients to fill potential gaps in a person’s diet for maintaining an active and healthy lifestyle. Common dietary supplements include vitamins, minerals, herbs and botanicals, probiotics, fish oil and more. To capture product-specific nuances, this report, where relevant, treats the OTC drugs market as being distinct from the vitamins and drug supplement market in its analysis.
Key players in the global OTC drugs, vitamins and dietary supplements market include Haleon Group of Companies, Kenvue, Opella Healthcare Group SAS, Bayer, Procter & Gamble, Reckitt, STADA Arzneimittel AG, Amway, Nestlé, Pharmavite, H&H Group, Herbalife, Church & Dwight and GNC Holdings. The market is highly fragmented. In addition to industry leaders, domestic players and store brands also play a vital role. Companies compete in terms of pricing strategies, product quality, innovation, brand recognition and distribution channels.
Segmental Analysis
In this report, the global OTC drugs, vitamins and dietary supplements market is segmented based on product type, point of sale and geographic region. Whereas vitamins and dietary supplements are treated as their own product type segment, OTC drugs are further segmented by product type into respiratory treatments, pain relief, digestive health, dermatological drugs, oral medical care, eye care and smoking cessation. Similarly, whereas the vitamins and dietary supplements market is categorized based on point of sale into the following segments: retail pharmacies and stores, e-commerce and other points of sale; the OTC drugs market is categorized as retail pharmacies and stores as well as epharmacies.Report Scope
This report provides an overview of the global over-the-counter (OTC) drugs, vitamins and dietary supplements market and analyzes trends in this market. It includes global revenue ($ million) for the base year of 2024, estimated market values for 2025, and market values for the forecast period 2025 through 2030. In this report, market revenue refers to ex-factory or ex-manufacturer sales, representing the value of goods as they leave the manufacturer and before any markups by wholesalers or retailers.The report focuses on the major driving trends and challenges that affect the OTC drugs, vitamins and dietary supplements market and its vendor landscape. It covers the latest new products, acquisitions and collaborations taking place in this market. It also analyzes environmental, social, and corporate governance (ESG) developments and discusses emerging opportunities and challenges related to the market.
The report concludes with an analysis of the competitive landscape of this market, providing the ranking and share of key players. It also has a company profiles section that is dedicated to providing details about leading market players.
It is important to note that this report’s scope covers only pharmacological OTC drugs and excludes any other types of drugs, such as alternative therapies. Also, dietary supplements for weight management, meal replacements, medical nutrition, sports nutrition, and skin care are not included in this report.
The report includes:
- 46 data tables and 59 additional tables
- An overview of the global market for over-the-counter drugs, vitamins and dietary supplements
- An analysis of the global market trends with market revenue data from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030
- Highlights of the current and future market potential and quantification of the market by product type, point of sales, and geographic region
- Discussion on market opportunities for over-the-counter drugs, vitamins and dietary supplement applications, industry structure, and regulatory scenarios
- Information on the latest developments in healthcare interoperability solutions and new industry research, upcoming technologies, and economic trends
- Identification of challenges and discussion on how to overcome those to reach its commercialization potential, and ESG trends of the market
- Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis
- Comprehensive company profiles of the leading players of the industry, including Haleon Group of Companies, Kenvue, Opella Healthcare Group SAS, Bayer AG, and Procter & Gamble
Table of Contents
Chapter 1 Executive Summary
Chapter 2 Market Overview
Chapter 3 Market Dynamics
Chapter 4 Regulatory Landscape
Chapter 5 Emerging Technologies and Developments
Chapter 6 Market Segmentation Analysis
Chapter 7 Competitive Intelligence
Chapter 8 Sustainability in OTC Drugs, Vitamins and Dietary Supplements Market: ESG Perspective
Chapter 9 Appendix
List of Tables
List of Figures
Companies Mentioned
- Abbott
- Amway Corp.
- Bayer AG
- DSM-Firmenich
- Haleon Group of Co.
- Herbalife Ltd.
- Kenvue
- Nestlé Health Science
- Opella Healthcare Group SAS
- Pharmavite
- Procter & Gamble
- Reckitt
- STADA Arzneimittel AG
- Taisho Pharmaceutical Holdings Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 155 |
| Published | May 2025 |
| Forecast Period | 2025 - 2030 |
| Estimated Market Value ( USD | $ 276.9 Billion |
| Forecasted Market Value ( USD | $ 371.7 Billion |
| Compound Annual Growth Rate | 6.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
